Our data from TRAF2 KO combined with Birinipant treatment indicated a significant depletion of RNF31 in the TNFR1 complex in sensitized tumor cells, despite unchanged cellular RNF31 protein levels (Figs. 2B and S2E, F). The gene discussed is TNFRSF1A; the disease is neoplasm.